Advances in precision medicine and bacteriophage engineering drive steady growth, despite regulatory and cost challenges.Austin, United States, April 21, 2026 (GLOBE NEWSWIRE) -- According to SNS ...

Growing antimicrobial resistance is prompting renewed interest in phage therapy, with preliminary data indicating improved outcomes when combined with standard antibiotics.

The concept of bacteriophage therapy explores using viruses that specifically infect and kill bacteria as a treatment for bacterial infections. Identification and engineering of phages that ...

According to the WHO, antibiotic resistance is one of the biggest threats to global health, food security, and development today: "Antibiotic resistance is rising to dangerously high levels in all ...

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded $2.5 million in grants to 12 institutes around the world to support research ...

A persistent infection in a pet cat’s leg after a compound fracture was repaired has finally been cured using cutting-edge experimental medicine: personalized bacteriophage therapy. Pet Siamese cat, ...

Phage therapy is emerging as a potential solution to antibiotic resistance and superbugs, with clinical advances in ...

The overuse of broad-spectrum antibiotics has led to the development of multi-resistant bacterial strains, rendering antibiotics useless in the treatment of many infectious diseases. As bacteriophages ...

In a recent review published in Cell, researchers presented an overview of bacteriophage treatment, including mechanisms, types, design and applications of bacteriophage therapy. Study: Phage therapy: ...

United States Global Bacteriophages Therapy Market document contains the drivers and restraints for the market that are obtained with the help of SWOT analysis, and also shows all the recent ...

Enrollment has begun in an early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis (CF) who carry Pseudomonas aeruginosa (P. aeruginosa) in their lungs. The trial is ...